Thymus Transplantation

  • M. Louise Markert
  • Blythe H. Devlin
  • Elizabeth A. McCarthy
  • Ivan K. Chinn
  • Laura P. Hale


Thymus transplantation was first attempted in the 1960s and 1970s using fetal thymus tissue [1, 2]. The results overall were disappointing [3, 4, 5, 6]. In part the poor outcomes related to the lack of reagents needed to characterize and identify the patients into those who were truly athymic (complete DiGeorge anomaly) and those who had bone marrow stem cell problems (severe combined immunodeficiency). It is also possible that the fetal thymus tissue was too small to reconstitute a human infant [7]. The use of fetal thymus carried the risk of fatal graft versus host disease since mature T-cells can be found in the human thymus by the end of the first trimester [3]. By 1986, in a review of 26 infants treated with fetal thymus transplantation, 22 had died; the other 4 patients had achieved a 3-year survival [6].


West Nile Virus Allergy Clin Immunol Graft Versus Host Disease Severe Acute Respiratory Syndrome Thymus Tissue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cleveland WW, Fogel BJ, Brown WT, Kay HE (1968) Foetal thymic transplant in a case of DiGeorge’s syndrome. Lancet 2:1211–1214PubMedCrossRefGoogle Scholar
  2. 2.
    August CS, Rosen FS, Filler RM et al (1968) Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (DiGeorge’s syndrome). Lancet 2:1210–1211PubMedCrossRefGoogle Scholar
  3. 3.
    Wara DW, Golbus MS, Ammann AJ (1974) Fetal thymus glands obtained from prostaglandin-induced abortions. Cellular immune function in vitro and evidence of in vivo thymocyte activity following transplantation. Transplantation 18:387–390PubMedCrossRefGoogle Scholar
  4. 4.
    Shearer WT, Wedner HJ, Strominger DB et al (1978) Successful transplantation of the thymus in Nezelof’s syndrome. Pediatrics 61:619–624PubMedGoogle Scholar
  5. 5.
    Pahwa S, Pahwa R, Incefy G et al (1979) Failure of immunologic reconstitution in a patient with the DiGeorge syndrome after fetal thymus transplantation. Clin Immunol Immunopathol 14:96–106PubMedCrossRefGoogle Scholar
  6. 6.
    Hong R (1986) Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol 40:136–141PubMedCrossRefGoogle Scholar
  7. 7.
    Hong R (1983) Thymus transplantation. Birth Defects Original Article Series 19:259–265PubMedGoogle Scholar
  8. 8.
    Hong R, Schulte-Wissermann H, Jarrett-Toth E et al (1979) Transplantation of cultured thymic fragments. II. Results in nude mice. J Exp Med 149:398–415PubMedCrossRefGoogle Scholar
  9. 9.
    Barry TS, Jones DM, Richter CB, Haynes BF (1991) Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: Differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J Exp Med 173:167–180PubMedCrossRefGoogle Scholar
  10. 10.
    Lobach DF, Scearce RM, Haynes BF (1985) The human thymic microenvironment. Phenotypic characterization of Hassall’s bodies with the use of monoclonal antibodies. J Immunol 134:250–257PubMedGoogle Scholar
  11. 11.
    McFarland EJ, Scearce RM, Haynes BF (1984) The human thymic microenvironment: Cortical thymic epithelium is an antigenically distinct region of the thymic microenvironment. J Immunol 133:1241–1249PubMedGoogle Scholar
  12. 12.
    Haynes BF, Scearce RM, Lobach DF, Hensley LL (1984) Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Exp Med 159:1149–1168PubMedCrossRefGoogle Scholar
  13. 13.
    Haynes BF, Denning SM, Singer KH, Kurtzberg J (1989) Ontogeny of T-cell precursors: A model for the initial stages of human T-cell development. Immunol Today 10:87–91PubMedCrossRefGoogle Scholar
  14. 14.
    van Ewijk W (1991) T-cell differentiation is influenced by thymic microenvironments. Annu Rev Immunol 9:591–615PubMedCrossRefGoogle Scholar
  15. 15.
    Markert ML, Watson TJ, Kaplan I et al (1997) The human thymic microenvironment during organ culture. Clin Immunol Immunopathol 82:26–36PubMedCrossRefGoogle Scholar
  16. 16.
    Picker LJ, Treer JR, Ferguson-Darnell B et al (1993) Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol 150:1105–1121PubMedGoogle Scholar
  17. 17.
    Markert ML, Hummell DS, Rosenblatt HM et al (1998) Complete DiGeorge syndrome: Persistence of profound immunodeficiency. J Pediatr 132:15–21PubMedCrossRefGoogle Scholar
  18. 18.
    Bastian J, Law S, Vogler L et al (1989) Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 115:391–396PubMedCrossRefGoogle Scholar
  19. 19.
    Muller W, Peter HH, Wilken M et al (1988) The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 147:496–502PubMedCrossRefGoogle Scholar
  20. 20.
    Thomas RA, Landing BH, Wells TR (1987) Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly. Am J Med Genet (Suppl) 3:43–66CrossRefGoogle Scholar
  21. 21.
    Hong R (1991) The DiGeorge anomaly. Immunodefic Rev 3:1–14PubMedGoogle Scholar
  22. 22.
    Conley ME, Beckwith JB, Mancer JF, Tenckhoff L (1979) The spectrum of the DiGeorge syndrome. J Pediatr 94:883–890PubMedCrossRefGoogle Scholar
  23. 23.
    Barrett DJ, Ammann AJ, Wara DW et al (1981) Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol 6:1–6PubMedGoogle Scholar
  24. 24.
    Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study. J Med Genet 34:798–804PubMedCrossRefGoogle Scholar
  25. 25.
    Robin NH, Shprintzen RJ (2005) Defining the clinical spectrum of deletion 22q11.2. J Pediatr 147:90–96PubMedCrossRefGoogle Scholar
  26. 26.
    Markert ML, Devlin BH, Alexieff MJ et al (2007) Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: Outcome of 44 consecutive transplants. Blood 109:4539–4547PubMedCrossRefGoogle Scholar
  27. 27.
    Wilson DI, Goodship JA, Burn J et al (1992) Deletions within chromosome 22q11 in familial congenital heart disease. Lancet 340:573–575PubMedCrossRefGoogle Scholar
  28. 28.
    Driscoll DA, Budarf ML, Emanuel BS (1992) A genetic etiology for DiGeorge syndrome: Consistent deletions and microdeletions of 22q11. Am J Hum Genet 50:924–933PubMedGoogle Scholar
  29. 29.
    Pagon RA, Graham JM Jr, Zonana J, Yong SL (1981) Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr 99:223–227PubMedCrossRefGoogle Scholar
  30. 30.
    Blake KD, Davenport SL, Hall BD et al (1998) CHARGE association: An update and review for the primary pediatrician. Clin Pediatr (Phila) 37:159–173CrossRefGoogle Scholar
  31. 31.
    Vissers LE, van Ravenswaaij CM, Admiraal R et al (2004) Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36:955–957PubMedCrossRefGoogle Scholar
  32. 32.
    Wang R, Martinez-Frias ML, Graham JM Jr (2002) Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach. J Pediatr 141:611–617PubMedCrossRefGoogle Scholar
  33. 33.
    Gosseye S, Golaire MC, Verellen G et al (1982) Association of bilateral renal agenesis and DiGeorge syndrome in an infant of a diabetic mother. Helv Paediatr Acta 37:471–474PubMedGoogle Scholar
  34. 34.
    Markert ML, Alexieff MJ, Li J et al (2004) Complete DiGeorge syndrome: Development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 113:734–741PubMedCrossRefGoogle Scholar
  35. 35.
    Archer E, Chuang TY, Hong R (1990) Severe eczema in a patient with DiGeorge’s syndrome. Cutis 45:455–459PubMedGoogle Scholar
  36. 36.
    Pirovano S, Mazzolari E, Pasic S et al (2003) Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. Immun Lett 86:93–97CrossRefGoogle Scholar
  37. 37.
    Omenn GS (1965) Familial Reticuloendotheliosis with Eosinophilia. New Engl J Med 273:427–432PubMedCrossRefGoogle Scholar
  38. 38.
    Villa A, Sobacchi C, Notarangelo LD et al (2001) V(D)J recombination defects in lymphocytes due to RAG mutations: Severe immunodeficiency with a spectrum of clinical presentations. Blood 97:81–88PubMedCrossRefGoogle Scholar
  39. 39.
    Rieux-Laucat F, Bahadoran P, Brousse N et al (1998) Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn’s syndrome. J Clin Invest 102:312–321PubMedCrossRefGoogle Scholar
  40. 40.
    Markert ML, Alexieff MJ, Li J et al (2004) Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood 104:2574–2581PubMedCrossRefGoogle Scholar
  41. 41.
    Douek DC, McFarland RD, Keiser PH et al (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690–695PubMedCrossRefGoogle Scholar
  42. 42.
    Ocejo-Vinyals JG, Lozano MJ, Sanchez-Velasco P et al (2000) An unusual concurrence of graft versus host disease caused by engraftment of maternal lymphocytes with DiGeorge anomaly. Arch Dis Child 83:165–169PubMedCrossRefGoogle Scholar
  43. 43.
    Gobbi A, Stoddart CA, Malnati MS et al (1999) Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J Exp Med 189:1953–1960PubMedCrossRefGoogle Scholar
  44. 44.
    Dictor M, Fasth A, Olling S (1984) Abnormal B-cell proliferation associated with combined immunodeficiency, cytomegalovirus, and cultured thymus grafts. Am J Clin Pathol 82:487–490PubMedGoogle Scholar
  45. 45.
    Borzy MS, Hong R, Horowitz SD et al (1979) Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. New Engl J Med 301:565–568PubMedGoogle Scholar
  46. 46.
    Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL (1985) Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39:461–472PubMedGoogle Scholar
  47. 47.
    Reece ER, Gartner JG, Seemayer TA et al (1981) Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res 41:4243–4247PubMedGoogle Scholar
  48. 48.
    2006. Title 21-Food and Drugs; Chapter I-Food and Drug Administration, Department of Health and Human; Subchapter L-Regulations Under Certain Other Acts Administered by the Food and Drug Administration, Part 1270 Human Tissue intended for Transplantation. Code of Federal RegulationsGoogle Scholar
  49. 49.
    Hong R, Moore AL (1996) Organ culture for thymus transplantation. Transplantation 61:444–448PubMedCrossRefGoogle Scholar
  50. 50.
    2006. Title 21-Food and Drugs; Chapter I-Food and Drug Administration, Department of Health and Human; Subchapter L-Regulations Under Certain Other Acts Administered by the Food and Drug Administration, Part 1271 Human Tissue Intended for Transplantation. Code of Federal RegulationsGoogle Scholar
  51. 51.
    Rice HE, Skinner MA, Mahaffey SM et al (2004) Thymic transplantation for complete DiGeorge syndrome: Medical and surgical considerations. J Pediatr Surg 39:1607–1615PubMedCrossRefGoogle Scholar
  52. 52.
    Ham Pong AJ, Cavallo A, Holman GH, Goldman AS (1985) DiGeorge syndrome: Long-term survival complicated by Graves disease. J Pediatr 106:619–620PubMedCrossRefGoogle Scholar
  53. 53.
    Brown JJ, Datta V, Browning MJ, Swift PG (2004) Graves’ disease in DiGeorge syndrome: Patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J Pediatr Endocrinol Metab 17:1575–1579PubMedGoogle Scholar
  54. 54.
    Choi JH, Shin YL, Kim GH et al (2005) Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res 63:294–299PubMedCrossRefGoogle Scholar
  55. 55.
    Scuccimarri R, Rodd C (1998) Thyroid abnormalities as a feature of DiGeorge syndrome: A patient report and review of the literature. J Pediatr Endocrinol Metab 11:273–276PubMedGoogle Scholar
  56. 56.
    Mazzolari E, Forino C, Guerci S et al (2007) Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 120:892–899PubMedCrossRefGoogle Scholar
  57. 57.
    Levy A, Michel G, Lemerrer M, Philip N (1997) Idiopathic thrombocytopenic purpura in two mothers of children with DiGeorge sequence: A new component manifestation of deletion 22q11? Am J Med Genet 69:356–359PubMedCrossRefGoogle Scholar
  58. 58.
    DePiero AD, Lourie EM, Berman BW et al (1997) Recurrent immune cytopenias in two patients with DiGeorge/velocardiofacial syndrome. J Pediatr 131:484–486PubMedCrossRefGoogle Scholar
  59. 59.
    Duke SG, McGuirt WF Jr, Jewett T, Fasano MB (2000) Velocardiofacial syndrome: Incidence of immune cytopenias. Arch Otolaryngol Head Neck Surg 126:1141–1145PubMedGoogle Scholar
  60. 60.
    Welch P, Rose NR, Kite JH Jr (1973) Neonatal thymectomy increases spontaneous autoimmune thyroiditis. J Immunol 110:575–577PubMedGoogle Scholar
  61. 61.
    Markert ML, Sarzotti M, Ozaki DA et al (2003) Thymic transplantation in complete DiGeorge syndrome: Immunologic safety evaluations in twelve patients. Blood 102:1121–1130PubMedCrossRefGoogle Scholar
  62. 62.
    Chinn IK DB, Li YJ, Markert ML (2008) Long-term tolerance to allogeneic thymus transplants in complete Di-George anomaly. Clinical Immunol 126:277–281CrossRefGoogle Scholar
  63. 63.
    Smith CA, Driscoll DA, Emanuel BS et al (1998) Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab 5:415–417Google Scholar
  64. 64.
    Kung SJ, Gripp KW, Stephan MJ et al (2007) Selective IgM deficiency and 22q11.2 deletion syndrome. Ann Allergy Asthma Immunol 99:87–92PubMedGoogle Scholar
  65. 65.
    Shearer W, Rosenblatt HM, Gelman RS et al (2003) Lymphocyte subsets in healthy children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112:973–980PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • M. Louise Markert
    • 1
  • Blythe H. Devlin
    • 2
  • Elizabeth A. McCarthy
    • 2
  • Ivan K. Chinn
    • 2
  • Laura P. Hale
    • 3
  1. 1.Department of Pediatrics and Department of ImmunologyDuke University Medical CenterDurhamUSA
  2. 2.Department of PediatricsDuke University Medical CenterDurhamUSA
  3. 3.Department of PathologyDuke University Medical CenterDurhamUSA

Personalised recommendations